Navigation Links
Savient in Medical News

Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)

... BRUNSWICK, N.J., Aug. 2 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...esponse letter," stated Paul Hamelin, President of savient Pharmaceuticals. "While we believe we have made s...ndicated. Conference Call Information savient will host a live webcast to discuss the approval o...

The Gout & Uric Acid Education Society (GUAES) Announces New Survey Results Highlighting Major Gaps in Public Awareness of Gout

... support the educational outreach of the Society. Gout Awareness Day sponsorship has been provided by Takeda Pharmaceuticals North America, Inc., and savient Pharmaceuticals, Inc. About the Survey This survey was conducted online within the United States by Harris Interactive from May 5 to May 7 ...

Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009

...BRUNSWICK, N.J., March 9 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that Paul Hamelin, President of savient Pharmaceuticals will be presenting at the upcoming...by logging on to the Investor Relations section of savient Pharmaceuticals' Web site, http://www.savient.com...

Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results

...BRUNSWICK, N.J., Feb. 25 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today repo... on these investments. CONFERENCE CALL savient will host a live web cast to review fourth quarter...international) Conf ID: 5547271 ABOUT savient PHARMACEUTICALS, INC. ...

Pegloticase BLA Filing Accepted for Priority Review by FDA

...BRUNSWICK, N.J., Dec. 29 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...e gout, under the auspices of an SPA from the FDA. savient has licensed exclusive worldwide rights to the tec...f Mountain View Pharmaceuticals, Inc. ABOUT savient PHARMACEUTICALS, INC. ...

Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th

... BRUNSWICK, N.J., Dec. 8 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today announced that Paul Hamelin, President of savient Pharmaceuticals will be presenting at the upcoming...by logging on to the Investor Relations section of savient Pharmaceuticals' web site, http://www.savient.com...

Savient's Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase

...BRUNSWICK, N.J., Nov. 19 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...he Committee. The Committee will work closely with savient officers, Dr. Robert Lamm and Dr. Zeb Horowitz, wh...sight Committee will play a key role in supporting savient during this important time as we work toward FDA a...

Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th

... Clement, President and Chief Executive Officer of savient Pharmaceuticals, will present a corporate update a...by logging on to the Investor Relations section of savient Pharmaceuticals' web site, http://www.savient.com...ble on the company's web site for 30 days. ABOUT savient PHARMACEUTICALS, INC. ...

New Drug Helps Relieve Gout

...e blood to target levels within a few hours in most patients. That's the conclusion of a study by researchers at Duke University Medical Center and savient Pharmaceuticals, the company that's developing the drug. The phase II clinical trial included 41 patients randomly selected to receive either four...

NBA Coach Maurice Cheeks Teams Up with the Gout & Uric Acid Education Society (GUAES) to Call a 'Time Out for Gout'

...rs are encouraged to support the educational outreach of the Society. Event sponsorship has been provided to the Gout & Uric Acid Education Society by savient Pharmaceuticals, Inc. and TAP Pharmaceutical Products, Inc. Media Contact: Elizabeth Baxter 212-367-6875 Eliza...
Savient in Medical Technology

Savient Provides Update on Pegloticase BLA

...BRUNSWICK, N.J., Feb. 12 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...y scheduled for March 5, 2009 will be rescheduled. savient will provide additional details regarding the resc...e gout, under the auspices of an SPA from the FDA. savient has licensed exclusive worldwide rights to the tec...

Savient Announces FDA's Advisory Panel to Review Pegloticase for Treatment-Failure Gout Patients

...BRUNSWICK, N.J., Jan. 28 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...ed for a drug of a new therapeutic class. savient submitted its BLA to the FDA on October 31, 2008 s...rug designation by the FDA in 2001. ABOUT savient PHARMACEUTICALS, INC. ...

Savient Pharmaceuticals Announces Acceptance of Two Gout-Related Abstracts for Poster Presentation at the European League Against Rheumatism (EULAR) 2007 Annual Congress

...ease visit the Congress website at www.eular.org savient licensed exclusive, worldwide rights to the techno...ark of Mountain View Pharmaceuticals, Inc. ABOUT savient PHARMACEUTICALS savient Pharmaceuticals is a biopharmaceutical company eng...
Savient in Biological Technology

FDA Appointed Arthritis Advisory Committee Recommends U.S. Food and Drug Administration Approval for KRYSTEXXA(TM) for Refractory Chronic Gout

... savient to Host Conference Call and Webcast on Wednesday, ...BRUNSWICK, N.J., June 16 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced ...ffering from TFG," said Paul Hamelin, President of savient Pharmaceuticals, Inc. "KRYSTEXXA has the potentia...

Savient Announces New Date for FDA Arthritis Advisory Panel Review of KRYSTEXXA(TM) for Treatment Failure Gout

...T BRUNSWICK, N.J., May 7 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...from the open label extension study. ABOUT savient PHARMACEUTICALS, INC. savient Pharmaceuticals, Inc. is a specialty biopharmaceut...

Savient Pharmaceuticals Reports First Quarter 2009 Financial Results

...T BRUNSWICK, N.J., May 6 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today repo...on these investments. CONFERENCE CALL savient will host a live web cast to review first quarter ... (international) Conf ID: 4393613 ABOUT savient PHARMACEUTICALS, INC. ...

Disability and Poor Quality of Life Associated With Treatment Failure Gout Patients

...T BRUNSWICK, N.J., May 5 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) announced ...same metrics reported by physicians. About savient Pharmaceuticals, Inc. savient Pharmaceuticals, Inc. is a specialty biopharmaceut...

Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering

...BRUNSWICK, N.J., April 3 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...sion web site at http://www.sec.gov , or from savient Pharmaceuticals, Inc. at One Tower Center, 14th Fl... and warrants described above are being offered by savient pursuant to a registration statement previously fi...

Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009

...o so by visiting the Investor Relations section of savient Pharmaceuticals' web site at http://www.savient.c...entering conference ID number 5547271. ABOUT savient PHARMACEUTICALS, INC. savient Pharmaceuticals, Inc. is a biopharmaceutical compa...

Savient Announces Appointment of David Gionco as Chief Financial Officer

...BRUNSWICK, N.J., Feb. 12 /PRNewswire-FirstCall/ -- savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) today anno...step in as Chief Financial Officer. Since joining savient in 2006, David has distinguished himself as a true...(TM) (pegloticase)," said Paul Hamelin, President, savient Pharmaceuticals. Mr. Gionco has spent more th...

Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th

... Clement, President and Chief Executive Officer of savient Pharmaceuticals will present a corporate update at...by logging on to the Investor Relations section of savient Pharmaceuticals' web site, http://www.savient.com...ble on the company's web site for 30 days. ABOUT savient PHARMACEUTICALS, INC. ...

Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results

...s earned on these investments. CONFERENCE CALL savient will host a live web cast to review third quarter ...5-9291 (international) Conf ID: 67897749 ABOUT savient PHARMACEUTICALS, INC. savient Pharmaceuticals is a biopharmaceutical company eng...

Savient Submits Biologics License Application (BLA) for pegloticase

...egloticase for an extended period of time. ABOUT savient PHARMACEUTICALS, INC. savient Pharmaceuticals is a biopharmaceutical company eng...nd the BLA was filed with the FDA in October 2008. savient has exclusively licensed worldwide rights to the t...
Other Tags
(Date:7/13/2014)... A Xarelto lawsuit webpage has been launched ... with the most current information regarding serious internal bleeding ... as well as the growing number of Xarelto ... The law firm is now offering free legal evaluations ... bleeding and related complications while using Xarelto, including:, ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 According to ... this is a comprehensive program that teaches people how ... peripheral neuropathy without medications. This program also provides ... symptoms of peripheral neuropathy , including numbness, prickling, burning, ... its review that this home treatment program can help ...
(Date:7/12/2014)... Recently, iFitDress.com, one of the world’s leading ... red evening gowns . What’s more, all these hot outfits ... The company’s senior spokesman states, “We are proud to announce ... is an enjoyable shopping experience. In addition to the big ... low prices do not always mean bad quality. All the ...
(Date:7/12/2014)... 12, 2014 The report, "Phthalic Anhydride ... Market by Application & Geography – Trends & Forecast ... analysis and forecasting of market volume and value. The ... derivatives separately. The market of phthalic anhydride is projected ... to $8,415.89 million by 2018, with a CAGR of ...
(Date:7/12/2014)... July 12, 2014 The Security Analytics ... 2013 to $3,376.6 million by 2019, at an expected ... 2019. The challenges to counter the increasing number of ... of outdated cyber defense systems in organizations are enormous. ... and remodeling their existing architecture to develop better and ...
Breaking Medicine News(10 mins):Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 2Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 3Health News:Xeralto Lawsuit Page Launched By Wright & Schulte LLC To Provide Information On Potential For Xarelto Bleeding Side Effects, Growing Litigation 4Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 2Health News:The Peripheral Neuropathy Program Review Exposes Randall Labrum's Peripheral Neuropathy Treatment Program – Vkool.com 3Health News:Discounted Red Evening Gown Announced by iFitDress.com 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4
(Date:7/11/2014)... study the proteins that let nerve cells send out ... upon a biological tactic that may offer a new ... safe and environmentally responsible way. , Their findingthat ... species and harmless for a closely related onesuggests that ... harming beneficial species like bees. A summary of the ...
(Date:7/10/2014)... Albuquerque, and other major cities in New Mexico, nearly ... municipal wastewater rather than precious potable water supplies. Across ... of all golf courses receive treated effluent. Reusing the ... Additionally, golf courses and homeowners alike fertilize their lawns ... is nitrate. A New Mexico State University turfgrass expert ...
(Date:7/10/2014)...  Pomerantz LLP has filed a class action ... "Company")(NYSE-MKT: PVCT) and certain of its officers.  The ... Middle District of Tennessee , ... consisting of all persons or entities who purchased ... 2013 and May 22, 2014, both dates inclusive ...
Breaking Biology News(10 mins):Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
Other Contents